Ronald Brenner
Psychiatry · Hempstead, NYNPI 1982631644
Payments from drug & device makers
Across 1,756 payments — averaging $6550.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3.5M
- AbbVie$1.4M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.2M
- Teva Pharmaceuticals USA, Inc.$911K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$724K
- Biogen$663K
- plus $3.1M from 34 others
Across 8 payments — averaging $239.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,502,048 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Hempstead
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
- Paul EderNew York$2.7M
- Horacio CapoteAmherst$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.